This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Regulatory / Pomerantz Investigates Qiagen...
Regulatory securities fraud investigation

Pomerantz Investigates Qiagen Securities Fraud

Analysis based on 18 articles · First reported May 19, 2026 · Last updated Jun 02, 2026

Sentiment
-50
Attention
4
Articles
18
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The market is negatively impacted by the news of a potential securities fraud investigation into Qiagen, leading to a significant drop in Qiagen's stock price. This event could lead to a class action lawsuit, affecting investor confidence in Qiagen.

Biotechnology Legal Services
Event Summary

Pomerantz LLP is investigating claims against Qiagen N.V. for alleged securities fraud and unlawful business practices. This investigation follows Qiagen's announcement of disappointing preliminary results for the first quarter of 2026 on April 27, 2026, which included a 1% decline in net sales and a 5% decline in QuantiFERON product sales. Following this news, Qiagen's stock price fell by $4.07 per share, or 10.69%, to close at $34.02 per share on April 28, 2026. Pomerantz LLP is encouraging affected investors to contact them regarding potential participation in a class action lawsuit.

Entities Involved
stock
Qiagen
Qiagen is under investigation for alleged securities fraud and unlawful business practices, which led to a significant drop in its stock price after announcing disappointing Q1 2026 preliminary results.
Importance 100.0 Sentiment -70.0
priv
Kirby McInerney LLP
This law firm is conducting an investigation on behalf of Qiagen>>> investors concerning potential violations of federal securities laws by Qiagen>>> and its senior management.
Importance 80.0 Sentiment 20.0
priv
Pomerantz LLP
Pomerantz LLP is initiating an investigation into Qiagen on behalf of its investors, potentially leading to a class action lawsuit.
Importance 80.0 Sentiment 20.0
per
Lauren Molinaro
Lauren Molinaro is a contact person at Kirby McInerney LLP>>> for investors interested in the investigation against Qiagen>>>.
Importance 30.0 Sentiment 0.0
per
Danielle Peyton
Danielle Peyton is a contact person at Pomerantz LLP for investors interested in joining the investigation against Qiagen.
Importance 30.0 Sentiment 0.0
loc
United States — New York
United States — New York is the location where Kirby McInerney LLP>>> is based.
Importance 10.0 Sentiment 0.0
exch
New York Stock Exchange
Qiagen's stock is traded on the New York Stock Exchange, where its price fell following the announcement of preliminary results.
Importance 10.0 Sentiment 0.0
Relationships
Kirby McInerney LLP related ↔ Pomerantz LLP
Kirby McInerney LLP related ↔ Lauren Molinaro
Kirby McInerney LLP related ↔ Danielle Peyton
Kirby McInerney LLP related ↔ New York Stock Exchange
Pomerantz LLP related ↔ Lauren Molinaro
Pomerantz LLP related ↔ Danielle Peyton
Pomerantz LLP related ↔ New York Stock Exchange
Lauren Molinaro related ↔ Danielle Peyton
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.